SUPN position history
The shares of Supernus Pharmaceuticals (SUPN) that Krensavage Asset Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q1: 431,986 shares, $14M, 7.8% of portfolio, New
- 2025 Q2: 472,376 shares, $15M, 7.9% of portfolio, Add +9.3%
- 2025 Q3: 363,479 shares, $17M, 7.4% of portfolio, Reduce −23.1%
- 2025 Q4: 313,499 shares, $16M, 5.5% of portfolio, Reduce −13.8%
- 2026 Q1: 280,681 shares, $15M, 5.7% of portfolio, Reduce −10.5%
- 2026 Q2: 280,681 shares, $13M, 5.0% of portfolio
- 2026 Q3: 350,681 shares, $15M, 5.7% of portfolio, Add +24.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|